Hematocrit Test Devices Market

The hematocrit blood test defines the proportion of red blood cells in the blood. Composition of blood mainly constitutes of white blood cells and red blood cells suspended in virtually clear fluid called serum. The hemoglobin or hematocrit test specifies the percentage of blood by volume that is composed of red blood cells.
Hematocrit Test Devices Market contains market size and forecasts of Hematocrit Test Devices in global, including the following market information:
Global Hematocrit Test Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hematocrit Test Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hematocrit Test Devices companies in 2021 (%)
The global Hematocrit Test Devices market was valued at 3411 million in 2021 and is projected to reach US$ 3920.8 million by 2028, at a CAGR of 2.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hematocrit Test Meter Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hematocrit Test Devices include Abbott, Roche, Danaher, Bio-Rad, Horiba, Siemens, Nihon Kohden, Mindray Medical and Boule Diagnostics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hematocrit Test Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hematocrit Test Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hematocrit Test Devices Market Segment Percentages, by Type, 2021 (%)
Hematocrit Test Meter
Hematocrit Test Analyzer
Others
Global Hematocrit Test Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hematocrit Test Devices Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Hematocrit Test Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hematocrit Test Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hematocrit Test Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hematocrit Test Devices revenues share in global market, 2021 (%)
Key companies Hematocrit Test Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hematocrit Test Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Roche
Danaher
Bio-Rad
Horiba
Siemens
Nihon Kohden
Mindray Medical
Boule Diagnostics
Sysmex